Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells ; volume:15 ; number:1 ; day:28 ; month:3 ; year:2015 ; pages:1-10 ; date:12.2015
BMC cancer ; 15, Heft 1 (28.3.2015), 1-10, 12.2015
- Urheber
-
Kim, Marianne K.
- Beteiligte Personen und Organisationen
-
James, Jana
Annunziata, Christina M.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1231-z
- URN
-
urn:nbn:de:1111-2016110622065
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Marianne K.
- James, Jana
- Annunziata, Christina M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells